A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Extensively Drug Resistant-Tuberculosis, XDR-TB
2008
Journal of Korean Medical Association
J Korean Med Assoc 2008; 51(2): 168 -175 M ultidrug resistant tuberculosis(MDR TB), resistant to at least the two main TB drugs isoniazid and rifampicin, has been a threat to TB control because the treatment requires more toxic drugs and longer period with poor treatment outcomes. Recently, more serious concerns have been raised about extensively drug resistant tuberculosis (XDR TB), which shows resistance to fluoroquinolones and aminoglycosides in addition to isoniazid and rifampicin. XDR TB
doi:10.5124/jkma.2008.51.2.168
fatcat:6na2ckdt7va35mpd2izyrtjn2y